MSHO Legislative Update: Key Changes for 2025
Stay Ahead of the Curve: Reimbursement Legislative Update 2025. Key Changes Impacting Your Practice – Don't Miss Out! Get the latest insights on critical reimbursement updates for 2025. Stay informed, ensure compliance, and prepare your practice for the year ahead.
YesRx is a non-profit improving health equity through medication access. Under the program, people can donate no-longer-needed cancer drugs or supplies to the repository, allowing them to be repurposed for patients in need. To learn more about this program click the link below.
Are you passionate about hematology and oncology? Are you considering a career in this dynamic and impactful field? Are you a Michigander? Whether you're a medical student, resident, or attending, our new group is here to support your journey!
Lung cancer is by far the leading cause of cancer death in the US, accounting for about 1 in 5 of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.
On a positive note, the number of new lung cancer cases continues to decrease, partly because more people are quitting smoking (or not starting).
November 12, 2024
NCCN Guidelines Updated for Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate.
Updated October 22, 2024
Follow legislation that MSHO is actively monitoring that may impact you and your patients.
MSHO Annual Review in Hematology
Join us for a symposium focused on the latest breakthroughs in hematology and oncology, aimed at improving care for blood disorders. We welcome physicians, fellows, residents, advanced practice providers, nurses, and all healthcare professionals eager to stay informed about the evolving landscape of this vital field.
Zoom Webinar
view event detailsZoom Webinar
view event details